乳酸极化SPP1+巨噬细胞促进脑内缺氧适应肿瘤进展
该研究通过单细胞RNA测序和空间转录组图谱分析全脑肿瘤微环境,发现缺氧适应肿瘤细胞经LGALS1招募巨噬细胞,并通过乳酸介导组蛋白乳酸化诱导其分化为SPP1+亚群。SPP1直接激活肿瘤细胞MAPK信号并抑制CD8+ T细胞毒性,而巨噬细胞SPP1缺失可延缓脑内缺氧适应肿瘤生长并增强抗PD-1疗效。
要点
- 脑内转移灶及间质型胶质母细胞瘤中HIF-1信号增强,赋予肿瘤生长优势。
- 缺氧适应肿瘤细胞通过乳酸-组蛋白乳酸化诱导SPP1+巨噬细胞分化。
- 靶向LDHA的stiripentol可抑制脑肿瘤进展并与抗PD-1治疗协同。
核心结论
- 脑内缺氧适应肿瘤细胞与SPP1+巨噬细胞相互依赖,靶向该轴可重塑微环境并增强抗PD-1疗效。
研究设计与样本
- 采用转基因小鼠、立体定向脑注射、流式细胞术、CRISPR/Cas9基因编辑、免疫组化、免疫荧光、qRT-PCR、Western blotting、 co-IP、DNA pulldown及ChIP等实验,并构建全脑肿瘤单细胞RNA测序和空间转录组图谱。
主要发现
- 与颅外部分相比,脑内转移灶及间质型胶质母细胞瘤中HIF-1信号增强,缺氧适应性介导脑内肿瘤生长优势。
- 缺氧适应肿瘤细胞通过LGALS1招募巨噬细胞,并经乳酸介导的组蛋白乳酸化诱导其向SPP1+亚群分化。
- SPP1直接激活肿瘤细胞MAPK信号促进生长,并抑制CD8+ T细胞毒性。
- 巨噬细胞SPP1基因缺失可延缓脑内缺氧适应肿瘤生长并增强抗PD-1治疗反应。
- 具血脑屏障通透性的stiripentol靶向LDHA可阻碍脑肿瘤进展并与抗PD-1治疗协同。
临床怎么用
- SPP1+巨噬细胞亚群可作为脑肿瘤微环境重塑的潜在治疗靶点。
- LDHA抑制剂stiripentol联合抗PD-1治疗可能为脑肿瘤提供新的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brain malignancies originating from the central nervous system and metastasizing from extracerebral tumors remain incurable, while the underlying mechanisms remain unclear. In this study, we comprehensively investigated the pan-brain tumor microenvironment. METHODS: We employed transgenic mice, stereotactic brain injections, flow cytometry, CRISPR/Cas9 gene editing, immunohistochemistry, immunofluorescence, quantitative reverse transcription-polymerase chain reaction, western blotting, co-immunoprecipitation, DNA pulldown assays, and chromatin immunoprecipitation. RESULTS: We constructed single-cell RNA sequencing and spatial transcriptome profiles of pan-brain tumors and identified the enhanced hypoxia-inducible factor 1 (HIF-1) signaling in the intracerebral metastases compared with extracerebral parts, as well as in mesenchymal-subtype glioblastomas. Hypoxic adaptability mediated by HIF-1 signaling confers a tumor growth advantage in the brain. Integrated analysis and experimental models revealed the co-localization and mutual dependence between brain tumor hypoxic adaptability and macrophage infiltration. Hypoxic adaptive tumor cells recruit macrophages via galectin 1 (LGALS1) and induce differentiation toward the secreted phosphoprotein 1 (SPP1)+ subpopulation via lactate-mediated histone lactylation. Secreted phosphoprotein 1 directly activates mitogen-activated protein kinase signaling in tumor cells to promote tumor growth and inhibits the cytotoxic activity of CD8+ T cells. Genetic SPP1 deficiency in macrophages delays hypoxic adaptive tumor growth in the brain and enhances the tumor response to anti-programmed cell death-1 (anti-PD-1) therapy. Preclinically, targeting lactate dehydrogenase A (LDHA) by stiripentol with blood-brain barrier permeability impedes brain tumor progression and synergizes with anti-PD-1 therapy. CONCLUSIONS: The interrelationship between hypoxic adaptive tumor cells and macrophages in the brain highlights the possibility of SPP1+ macrophage-based microenvironment remodeling in brain tumor therapy.
引用
- Zhang J, Li Z, Yin J, et al. SPP1+ macrophages polarized by lactate confer the progression of hypoxic adaptive tumor cells in brain. Neuro Oncol. 2026. PMID: 40973181. doi:10.1093/neuonc/noaf208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。